We have analyzed a cloned #{176}-thalassemia ($#{176}-thal) gene from a patient doubly heterozygous for hemoglobin Lepore and $#{176}-thalassemia. Studies of 3H-uridine incorporation into 9-globin mRNA in this patient ' thalassemia gene generated five-to tenfold less fl-mRNA than a normal /9-gene in both nuclear and cytoplasmic RNA, simulating the results observed in vivo. Moreover, the small amount of fl#{176}-39 mRNA produced was as stable as normal fi-mRNA during an actinomycin D chase. ruling out rapid cytoplasmic turnover as a cause of the reduced accumulation.
Cotransfection of the $#{176}-39 thalassemia gene with a mutant tyrosine suppressor tRNA gene resulted in restoration of the fl#{176}-39 mRNA accumulation to near-normal levels.
On the basis of these results. we suggest that the low levels of -mRNA known to exist in the common form of #{176}-thalassemia, $#{176}-39 thalassemia, result from a lesion in transcription, or early posttranscriptional processes; the defect appears to be corrected by restoration of proper translational potential to the mutant mRNA.
at least in a gene transfer-expression system in tissue-culture cells. DNA containing these regions had no effect on the results.
(2) The defect can be corrected with a specific amber suppressor tRNA (Fig 7) . Our data (Tables 1 and 2) also imply strongly that an intranuclear defect in /3-mRNA accumulation occurs in vivo. 
